Visual And Refractive Outcomes In Hyperopic Pseudophakic Patients Implanted With A Trifocal Intraocular Lens

• Published in: Clinical ophthalmology (Auckland, N.Z.) Vol. 13; pp. 2261 - 2268
• Main Authors: Alfonso, José F, Fernández-Vega-Cueto, Andrés, Alfonso-Bartolozzi, Belén, Rodríguez-Uña, Ignacio, Montés-Micó, Robert
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.11.2019; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Analysis; cataract; Cataract extraction; Cataracts; Cornea; Design; Eye surgery; Hyperopia; Medical research; Original Research; Patients; phacoemulsification; Studies; Surgery; Transplants & implants; trifocal intraocular lens; Spain; cataract; hyperopia; trifocal intraocular lens; phacoemulsification
• ISSN: 1177-5467; 1177-5483; 1177-5483
• DOI: 10.2147/OPTH.S229228

To assess visual and refractive results after bilateral implantation of a trifocal intraocular lens (IOL) in patients with hyperopia. In a retrospective nonrandomized study, 196 eyes of 98 patients had bilateral implantation of a trifocal IOL. The Barrett Universal II formula was used for IOL power calculation. Eyes were divided into two groups for their analysis: low-moderate, with IOL power ranging from 22 to 26 D, and high, with IOL power ranging from 25 to 34 D. Refractive error was used to assess predictability, and corrected distance visual acuity (CDVA) and uncorrected distance visual acuity values were used to assess efficacy and safety of the surgery. Six months postoperatively, our results revealed a Snellen decimal CDVA of 0.97±0.05 and 0.94±0.09, for the low-moderate and high groups, respectively. The low-moderate hyperopia group showed a 75.23% of eyes with 20/20 of CDVA and 100% of eyes with 20/25 of CDVA, and the high hyperopia group showed 60.95% and 94.29% for these values of visual acuity, respectively. The mean postoperative spherical equivalent was -0.25±0.36D and -0.24±0.42D for low-moderate and high hyperopia groups, respectively. In the case of low-moderate hyperopia group, 81% of eyes were within ±0.50D and 99% within ±1.00D. These values were 78% and 95%, respectively, for the high hyperopic eyes. Bilateral implantation of a trifocal IOL in hyperopic eyes provided good visual and refractive outcomes. The Barrett Universal II formula was accurate in predicting the IOL power in hyperopic eyes.